Thompson Street Capital Partners Acquires Bioreclamation

ST. LOUIS (April 25, 2013) – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that they have acquired Westbury, New York-based Bioreclamation, a worldwide provider of biological products to life sciences and pharmaceutical companies. Terms of the transaction were not disclosed.

Said Jim Cooper, Managing Partner of TSCP, “Bioreclamation has an excellent management team, highly specialized and sophisticated sourcing and quality control processes, and the unique capability to offer a full continuum of biologics and differentiated in-vitro research tools to our pharmaceutical research customers,” Added Cooper, “We are excited to work with management to continue growing the business, while maintaining Bioreclamation’s industry-leading focus on product breadth, quality and customer service.”

###